ALLO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Allogene Therapeutics Inc (ALLO).


$446.60M Market Cap.

As of 03/13/2025 5:00 PM ET (MRY) • Disclaimer

ALLO Market Cap. (MRY)


ALLO Shares Outstanding (MRY)


ALLO Assets (MRY)


Total Assets

$548.71M

Total Liabilities

$126.53M

Total Investments

$297.93M

ALLO Income (MRY)


Revenue

$22.00K

Net Income

-$257.59M

Operating Expense

$273.22M

ALLO Cash Flow (MRY)


CF Operations

-$200.30M

CF Investing

$75.69M

CF Financing

$116.67M

ALLO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ALLO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$548,710,000 (-14.64%)

$642,837,000 (-21.32%)

$817,079,000 (-21.33%)

$1,038,634,000 (-15.41%)

Assets Current

$303,386,000 (-33.92%)

$459,115,000 (-13.18%)

$528,824,000 (12.20%)

$471,323,000 (-44.23%)

Assets Non-Current

$245,324,000 (33.53%)

$183,722,000 (-36.26%)

$288,255,000 (-49.19%)

$567,311,000 (48.24%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$422,179,000 (-17.58%)

$512,233,000 (-23.07%)

$665,870,000 (-27.34%)

$916,406,000 (-15.12%)

Property Plant & Equipment Net

$131,261,000 (-19.56%)

$163,181,000 (-16.93%)

$196,431,000 (8.51%)

$181,020,000 (13.04%)

Cash & Equivalents

$85,510,000 (-8.49%)

$93,447,000 (29.44%)

$72,196,000 (-60.68%)

$183,606,000 (-4.77%)

Accumulated Other Comprehensive Income

-$89,000 (90.68%)

-$955,000 (90.38%)

-$9,926,000 (-286.68%)

-$2,567,000 (-1057.84%)

Deferred Revenue

$0 (0%)

$86,000 (-90.28%)

$885,000 (109.22%)

$423,000 (-98.92%)

Total Investments

$297,931,000 (-19.30%)

$369,187,000 (-30.00%)

$527,384,000 (-19.38%)

$654,172,000 (-23.26%)

Investments Current

$217,258,000 (-40.57%)

$365,542,000 (-19.73%)

$455,416,000 (60.36%)

$283,988,000 (-55.94%)

Investments Non-Current

$80,673,000 (2113.25%)

$3,645,000 (-94.94%)

$71,968,000 (-80.56%)

$370,184,000 (78.02%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$5,394,000 (-8.53%)

$5,897,000 (-57.54%)

$13,890,000 (35.45%)

$10,255,000 (-1.30%)

Accumulated Retained Earnings (Deficit)

-$1,819,823,000 (-16.49%)

-$1,562,233,000 (-26.40%)

-$1,235,980,000 (-36.82%)

-$903,348,000 (-39.76%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$95,122,000 (0%)

$0 (0%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$95,122,000 (0%)

$0 (0%)

Total Liabilities

$126,531,000 (-3.12%)

$130,604,000 (-13.63%)

$151,209,000 (23.71%)

$122,228,000 (-17.53%)

Liabilities Current

$35,523,000 (-4.20%)

$37,079,000 (-31.99%)

$54,518,000 (13.17%)

$48,174,000 (-48.92%)

Liabilities Non-Current

$91,008,000 (-2.69%)

$93,525,000 (-3.27%)

$96,691,000 (30.57%)

$74,054,000 (37.41%)

ALLO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$22,000 (-76.84%)

$95,000 (-60.91%)

$243,000 (-99.37%)

$38,489,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$65,205,000 (-9.02%)

$71,673,000 (-9.62%)

$79,305,000 (7.02%)

$74,105,000 (13.56%)

Research & Development Expense

$192,299,000 (-20.84%)

$242,914,000 (-5.25%)

$256,387,000 (16.45%)

$220,176,000 (14.09%)

Operating Expenses

$273,221,000 (-16.66%)

$327,832,000 (-2.34%)

$335,692,000 (14.07%)

$294,281,000 (13.96%)

Interest Expense

$181,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$443,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$257,590,000 (21.29%)

-$327,265,000 (1.61%)

-$332,632,000 (-29.43%)

-$257,005,000 (-2.71%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$257,590,000 (21.29%)

-$327,265,000 (1.61%)

-$332,632,000 (-29.43%)

-$257,005,000 (-2.71%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$257,590,000 (21.29%)

-$327,265,000 (1.61%)

-$332,632,000 (-29.43%)

-$257,005,000 (-2.71%)

Weighted Average Shares

$194,811,756 (24.14%)

$156,931,778 (9.63%)

$143,147,165 (5.39%)

$135,820,386 (12.84%)

Weighted Average Shares Diluted

$194,811,756 (24.14%)

$156,931,778 (9.63%)

$143,147,165 (5.39%)

$135,820,386 (12.84%)

Earning Before Interest & Taxes (EBIT)

-$256,966,000 (21.48%)

-$327,265,000 (1.61%)

-$332,632,000 (-29.43%)

-$257,005,000 (-2.71%)

Gross Profit

$22,000 (-76.84%)

$95,000 (-60.91%)

$243,000 (-99.37%)

$38,489,000 (0%)

Operating Income

-$273,199,000 (16.64%)

-$327,737,000 (2.30%)

-$335,449,000 (-31.14%)

-$255,792,000 (0.95%)

ALLO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$75,688,000 (-53.65%)

$163,289,000 (53.82%)

$106,159,000 (-35.13%)

$163,655,000 (132.40%)

Net Cash Flow from Financing

$116,675,000 (21.92%)

$95,695,000 (3143.90%)

$2,950,000 (-75.34%)

$11,963,000 (-98.11%)

Net Cash Flow from Operations

-$200,300,000 (15.75%)

-$237,733,000 (-7.81%)

-$220,519,000 (-19.32%)

-$184,812,000 (-60.58%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$7,937,000 (-137.35%)

$21,251,000 (119.07%)

-$111,410,000 (-1111.77%)

-$9,194,000 (-168.74%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$76,382,000 (-53.65%)

$164,805,000 (48.01%)

$111,350,000 (-39.84%)

$185,101,000 (142.15%)

Capital Expenditure

-$694,000 (54.22%)

-$1,516,000 (70.80%)

-$5,191,000 (75.80%)

-$21,446,000 (67.49%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$114,395,000 (19.54%)

$95,695,000 (3143.90%)

$2,950,000 (-75.34%)

$11,963,000 (-98.11%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$51,743,000 (-21.54%)

$65,951,000 (-21.11%)

$83,600,000 (3.44%)

$80,818,000 (23.84%)

Depreciation Amortization & Accretion

$13,639,000 (-3.94%)

$14,199,000 (-0.67%)

$14,295,000 (36.74%)

$10,454,000 (40.61%)

ALLO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00%

Profit Margin

-1170863.60% (-239.88%)

-344489.50% (-151.66%)

-136885.60% (-20401.06%)

-667.70%

EBITDA Margin

-1106031.80% (-235.63%)

-329543.20% (-151.55%)

-131002.90% (-20350.03%)

-640.60%

Return on Average Equity (ROAE)

-55.30% (2.47%)

-56.70% (-30.65%)

-43.40% (-68.22%)

-25.80% (-2.38%)

Return on Average Assets (ROAA)

-43.50% (4.61%)

-45.60% (-23.91%)

-36.80% (-58.62%)

-23.20% (-1.75%)

Return on Sales (ROS)

-1168027.30% (-239.06%)

-344489.50% (-151.66%)

-136885.60% (-20401.06%)

-667.70%

Return on Invested Capital (ROIC)

-53.20% (-1.72%)

-52.30% (-34.79%)

-38.80% (-32.42%)

-29.30% (0.34%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.61 (-5.08%)

-1.54 (43.34%)

-2.71 (65.66%)

-7.89 (34.95%)

Price to Sales Ratio (P/S)

18,861.24 (255.70%)

5,302.63 (43.11%)

3,705.34 (6937.68%)

52.65

Price to Book Ratio (P/B)

1.06 (0.28%)

1.05 (-22.54%)

1.36 (-41.29%)

2.32 (-29.27%)

Debt to Equity Ratio (D/E)

0.3 (17.65%)

0.26 (12.33%)

0.23 (70.68%)

0.13 (-2.92%)

Earnings Per Share (EPS)

-1.32 (36.84%)

-2.09 (9.91%)

-2.32 (-22.75%)

-1.89 (9.13%)

Sales Per Share (SPS)

0 (0%)

0 (-50.00%)

0 (-99.29%)

0.28 (0%)

Free Cash Flow Per Share (FCFPS)

-1.03 (32.33%)

-1.52 (3.30%)

-1.58 (-3.82%)

-1.52 (-1.00%)

Book Value Per Share (BVPS)

2.17 (-33.61%)

3.26 (-29.84%)

4.65 (-31.05%)

6.75 (-24.77%)

Tangible Assets Book Value Per Share (TABVPS)

2.82 (-31.23%)

4.1 (-28.24%)

5.71 (-25.36%)

7.65 (-25.03%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (0.00%)

-2 (33.33%)

-3 (62.50%)

-8 (38.46%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.93 (-9.84%)

-1.76 (39.07%)

-2.89 (64.01%)

-8.02 (42.27%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0.04 (0%)

Current Ratio

8.54 (-31.02%)

12.38 (27.65%)

9.7 (-0.86%)

9.78 (9.20%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$200,994,000 (15.99%)

-$239,249,000 (-6.00%)

-$225,710,000 (-9.43%)

-$206,258,000 (-13.92%)

Enterprise Value (EV)

$470,205,554 (-14.62%)

$550,732,085 (-40.08%)

$919,138,869 (-53.52%)

$1,977,506,795 (-41.37%)

Earnings Before Tax (EBT)

-$257,147,000 (21.43%)

-$327,265,000 (1.61%)

-$332,632,000 (-29.43%)

-$257,005,000 (-2.71%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$243,327,000 (22.28%)

-$313,066,000 (1.66%)

-$318,337,000 (-29.12%)

-$246,551,000 (-1.55%)

Invested Capital

$427,677,000 (-16.52%)

$512,311,000 (-34.78%)

$785,487,000 (-2.65%)

$806,854,000 (-14.23%)

Working Capital

$267,863,000 (-36.53%)

$422,036,000 (-11.02%)

$474,306,000 (12.09%)

$423,149,000 (-43.64%)

Tangible Asset Value

$548,710,000 (-14.64%)

$642,837,000 (-21.32%)

$817,079,000 (-21.33%)

$1,038,634,000 (-15.41%)

Market Capitalization

$446,601,554 (-17.32%)

$540,168,085 (-40.45%)

$907,081,869 (-57.34%)

$2,126,337,795 (-39.95%)

Average Equity

$465,583,000 (-19.40%)

$577,625,750 (-24.57%)

$765,752,500 (-23.04%)

$994,984,750 (0.29%)

Average Assets

$592,765,750 (-17.47%)

$718,251,250 (-20.57%)

$904,231,750 (-18.24%)

$1,105,912,000 (0.60%)

Invested Capital Average

$482,643,500 (-22.81%)

$625,290,750 (-27.14%)

$858,215,500 (-2.26%)

$878,067,000 (3.30%)

Shares

209,672,091 (24.60%)

168,276,662 (16.69%)

144,210,154 (1.19%)

142,515,938 (1.59%)